Condensed Statements of Shareholders' Deficiency - USD ($)	3 Months Ended		6 Months Ended
	Jul. 31, 2022	Jul. 31, 2021	Jul. 31, 2022	Jul. 31, 2021
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance (in shares)			1,233,853
Beginning balance	$ (953,397)	$ (856,672)	$ (930,624)	$ (835,505)
Net loss	$ (25,750)	(20,864)	$ (48,523)	(42,031)
Ending balance (in shares)	1,233,853		1,233,853
Ending balance	$ (979,147)	$ (877,536)	$ (979,147)	$ (877,536)
Common Stock
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance (in shares)	1,233,853	1,233,853	1,233,853	1,233,853
Beginning balance	$ 1,233	$ 1,233	$ 1,233	$ 1,233
Ending balance (in shares)	1,233,853	1,233,853	1,233,853	1,233,853
Ending balance	$ 1,233	$ 1,233	$ 1,233	$ 1,233
Additional Paid-in Capital
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance	81,323	81,323	81,323	81,323
Ending balance	81,323	81,323	81,323	81,323
Accumulated Deficit
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance	(1,035,953)	(939,228)	(1,013,180)	(918,061)
Net loss	(25,750)	(20,864)	(48,523)	(42,031)
Ending balance	$ (1,061,703)	$ (960,092)	$ (1,061,703)	$ (960,092)